Coenzyme Q at the Hinge of Health and Metabolic Diseases.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing biological mechanisms and clinical associations without systematic review methodology.
PubMed 34829656 · doi:10.3390/antiox10111785
What was done
This narrative review synthesizes literature on coenzyme Q (CoQ), covering its endogenous biosynthesis, mitochondrial functions in ATP generation, extramitochondrial antioxidant mechanisms, human primary and secondary CoQ deficiency syndromes, and the therapeutic potential of CoQ supplementation in aging and metabolic diseases.
What was found
The abstract provides no quantitative data, effect sizes, or specific trial metrics. It summarizes that CoQ is essential for maintaining aerobic metabolism, cellular redox homeostasis, and apoptosis regulation, while noting that CoQ deficiency contributes to heterogeneous mitochondrial disorders and that supplementation has demonstrated benefits for age-associated metabolic conditions and physical performance.
Why it matters
The review synthesizes mechanistic pathways connecting CoQ cellular biochemistry to systemic metabolic dysfunction and aging, framing the rationale for clinical supplementation strategies.
Limits
The paper is an unsystematic narrative review rather than an empirical trial or meta-analysis. The abstract provides no primary data, sample sizes, or quantitative outcome metrics, making it impossible to independently assess the magnitude or consistency of clinical benefits associated with CoQ supplementation.